Eveline K. Hoebe

Statistics

Publications

Citations

265

H-Index

Active since

2006

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

University of Georgia

University of Wisconsin–Madison

Universitas Gadjah Mada

Taiho Pharmaceutical (Japan)

Eveline K. Hoebe is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in pharmacology, life sciences, and molecular biology.

Publications per year

2006–2018

Publications

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells

Olaf H. Temmink, Eveline K. Hoebe, Kasper van der Born et al. · British Journal of Cancer · 2007 · 50 citations · Full text

Medicine, Oncology, Pharmacology +13

Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine

Olaf H. Temmink, Eveline K. Hoebe, Masakazu Fukushima et al. · European Journal of Cancer · 2006 · 35 citations

Medicine, Oncology, Pharmacology +10

Purified Hexameric Epstein-Barr Virus-Encoded BARF1 Protein for Measuring Anti-BARF1 Antibody Responses in Nasopharyngeal Carcinoma Patients

Eveline K. Hoebe, Susanna Hilda Hutajulu, Janko van Beek et al. · Clinical and Vaccine Immunology · 2010 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation

Eveline K. Hoebe, Tessa Y. S. Le Large, Nicolas Tarbouriech et al. · Viral Immunology · 2012 · 28 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent

J. Sigmond, J. A. E. Kamphuis, Adrianus C. Laan et al. · Biochemical Pharmacology · 2007 · 25 citations

Medicine, Molecular Biology, Pharmacology +3

1–5 of 11